K, Wase AM. Medulloblastoma: Is the 5-year survival rate improving? A
review of 80 cases from a single institution. J Neurosurg 1997;86:13-2 I.
\[8\] Packer RJ, Sutton LN, EIterman R, Lange B, Goldwein J,
Nicholson S, Mulne L, et al. Outcome for children with medulloblastoma
treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg 1994;81:690-8.
\[9\] Lansky LL, List MA, Lansky SB, Cohen ME, Sinks LF. Toward
the development of a play performance scale of children (PPSC). Cancer
1985;56:1837-40.
\]10\] Packer RJ, Siegel KR, Sutton LN, Evans AE, D'Angio G,
Rorke LB, Bunin GR, Schut L. Efficacy of adjuvant chemotherapy for
patients with poor-risk medalloblastoma: A preliminary report. Ann
Neurol 1988;24:503-8.
\[11\] Packer RJ. Chemotherapy for medulloblastoma/primitive neuroectodermal tumors of the posterior fossa. Ann Neurol 1990;28:823-8.
\[12\] Lefkowitz IB, Packer RJ, Siegal KR, Sutton LN, Schut L,
Evans AE. Results of treatment of children with recurrent medulloblastomaJprimitive neuroectodermal tumors with Iomustine, cisplatin and
vincristine. Cancer 1990;65:412-7.
\[13\] Packer RJ, Sutton LN, Goldwein JW, Perilongo G, Bunin G,
Ryan J, Cohen BH, et al. Improved survival with the use of adjuvant
chemotherapy in the treatment of medulloblastoma. J Neurosurg 1991;
74:433-40.
\[14\] Lewis IJ, Stevens MCG, Pearson A, Pinkerton R, Stevens R.
Phase II study of carboplatin in children's tumours. United Kingdom
Children's Cancer Study Group, University of Leicester, UK (abstract).
Proc Am Soc Clin Oncol 1993;12:121.
\[15\] Kovnar E, Heideman R, Kellie S, Douglass E, Greenwald C,
Kuttesch J, Ochs J, et al. Carboplatin and VP-16 in the treatment of high
stage medulloblastoma, pineoblastoma and supratentorial PNET (ab-stract). Proc Am Soc Clin Oncol 1993;12:425.
\[16\] Lewis IJ, Stevens MCG, Pearson A, Pinkerton CR, Stevens R.
Phase II study of carboplatin in children's tumors (abstract). Proc Am
Soc Clin Oncol 1993;12:412.
\[17\] Ashley DM, Meier L, Kerby T, Zalduondo M, Friedman HS,
Gajjar A, Kun L, et al. Response of recurrent medulloblastoma to
low-dose oral etoposide. J Clin Oncol 1996;14:1922-7.
\[18\] Chamberlain MC. Recurrent brainstem gliomas treated with
oral VP-16. J Neuro-Oncol 1993;15:133-9.
\[19\] Chamberlain MC. Recurrent supratentorial gliomas: Salvage
therapy with oral etoposide (abstract). Ann Neurol 1996;40:335.
\[20\] Chamberlain MC. Recurrent cerebellar gliomas: Salvage therapy with oral VP-16. Child Neurol 1997;12:200-4.
\[21\] Chamberlain MC, Grafe MR. Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide. J Clin Oncol 1995;13:2072-6.
\[22\] Hainsworth JD, Greco FA. Etoposide: Twenty years later. Ann
Oncol 1995;6:325-41.
\[23\] Greco FA, Johnson DH, Hainsworth JD. Chronic oral etoposide. Cancer 1991;67:303-9.
\[24\] MacDonald DR, Cascino TL, Schald SC Jr, Cairncross JG.
Response criteria for phase II studies of supratentorial malignant glioma.
J Clin Oncol 1990;8:1277-80.
